Latest filing published 24 Apr 2019 for Cryo Cell International INC, €24k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -8.6%Entry US$7.00 · Close at T+365 US$6.40
- +0.1%Entry US$8.00 · Close at T+365 US$8.01
- -10.5%Entry US$7.91 · Close at T+365 US$7.08
- -7.5%Entry US$8.14 · Close at T+365 US$7.53
- -6.3%Entry US$8.05 · Close at T+365 US$7.54
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Arthur Ellis: trading record in brief
Arthur Ellis is a declared insider of Cryo Cell International Inc, with filings sourced from SEC (Form 4). In total, 7 filings cover trades dated from 21 August 2018 to 17 April 2019.
Every open-market trade on record is a purchase: 7 purchases worth €88k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2019: 1 purchase and no sales on the market.
Half of the purchases are above €10k and half below. 6 out of 7 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 7 purchases with a full 90-day history, the hit rate stands at 14% and the median 90-day move at -11.5%. These figures describe past trades and do not predict future prices.
The latest filing, published on 24 April 2019, reports an open-market purchase of €24k in Cryo Cell International Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Arthur Ellis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,853 shares@ US$6.9026.8% of flowCommon StockSEC:0000899243-19-011038:0Canonical exit: 16 Jul 2019 (T+90)
- 5,000 shares@ US$6.8033.7% of flowCommon StockSEC:0000899243-18-027298:0Canonical exit: 21 Jan 2019 (T+90)
- 1,000 shares@ US$8.007.8% of flowCommon StockSEC:0000899243-18-023731:0Canonical exit: 28 Nov 2018 (T+90)
- 1,975 shares@ US$7.9015.2% of flowCommon StockSEC:0000899243-18-023731:1Canonical exit: 28 Nov 2018 (T+90)
- 40 shares@ US$8.000.3% of flowCommon StockSEC:0000899243-18-023300:0Canonical exit: 22 Nov 2018 (T+90)
- 1,500 shares@ US$8.0511.9% of flowCommon StockSEC:0000899243-18-023025:0Canonical exit: 19 Nov 2018 (T+90)
- 550 shares@ US$8.004.3% of flowCommon StockSEC:0000899243-18-023025:1Canonical exit: 19 Nov 2018 (T+90)
7 of 7 declarations
